Skip to main content

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

Objective

PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players. Much needed processes and tools for three key decision-making points (research priority setting, design of clinical trials and early dialogue) will be developed by consensus. Building on advances at international level, PARADIGM will integrate the needs, perspectives and expectations of all actors (including vulnerable populations) involved and will also produce a stakeholder-tailored set of metrics to measure the impact of PE.
PARADIGM will deliver to the community, recommendations and tools to support the implementation of PE, leveraging pre-existing resources. These will address capacity and capability questions, managing potential conflict of interest, the compensation of individuals and organisations, and the ethics of engagement. A targeted communication, dissemination and engagement strategy will promote the endorsement of the outputs for their integration in existing structures.
PARADIGM will develop a strategy for sustaining the long-term implementation of PE resources aimed at structuring and supporting the community. This will be a game-changer, addressing fundamental gaps and creating real assets to ensure the sustainability of the PE ecosystem in the years to come.
PARADIGM has a common vision and values-base, and is a highly innovative, consensus-oriented, and experienced consortium, comprising pan-European leaders in patient engagement, academia, SMEs, health professionals, pharmaceutical and biotech companies, pharmaceutical corporate associations, and representatives of competent authorities, all bringing complementary know-how to partner with industry, and a strong commitment to transform patient engagement in Europe.

Call for proposal

H2020-JTI-IMI2-2016-10-two-stage
See other projects for this call

Coordinator

FORUM DES PATIENTS EUROPEENS
Address
Chaussee D Etterbeek 180
BRUSSELS 1040
Belgium
Activity type
Other
EU contribution
€ 702 516

Participants (34)

EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION
France
EU contribution
€ 463 597,50
Address
Rue Didot 96
75014 Paris
Activity type
Other
EUROPEAN AIDS TREATMENT GROUP EV
Germany
EU contribution
€ 381 750
Address
Mettmanner Strasse 24-26
40233 Dusseldorf
Activity type
Other
ALZHEIMER EUROPE
Luxembourg
EU contribution
€ 248 500
Address
Rue Dicks 14
1417 Luxembourg
Activity type
Other
AGENZIA ITALIANA DEL FARMACO
Italy
EU contribution
€ 50 000
Address
Via Del Tritone 181
00187 Roma
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY
Canada
EU contribution
€ 0
Address
10405 Jasper Avenue Suite 1200
T5J 3N4 Edmonton
Activity type
Other
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD
Spain
EU contribution
€ 181 086,25
Address
Avenida San Juan Bosco 13
50009 Zaragoza
Activity type
Research Organisations
FUNDACIO PRIVADA PER A LA RECERCA I LA DOCENCIA SANT JOAN DE DEU
Spain
EU contribution
€ 176 125
Address
Calle Santa Rosa, 39-57
08950 Esplugues De Llobregat
Activity type
Research Organisations
STICHTING VU-VUMC
Netherlands
EU contribution
€ 458 437,50
Address
De Boelelaan 1105
1081 HV Amsterdam
Activity type
Higher or Secondary Education Establishments
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom
EU contribution
€ 621 592,50
Address
University Offices, Wellington Square
OX1 2JD Oxford
Activity type
Higher or Secondary Education Establishments
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE
Belgium
EU contribution
€ 198 000
Address
Rue De Washington 40
1050 Brussels
Activity type
Other
THE SYNERGIST
Belgium
EU contribution
€ 543 828,75
Address
Avenue Louise 523
1050 Bruxelles
Activity type
Other
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL

Participation ended

Spain
EU contribution
€ 399 594,65
Address
Calle Velazquez 94 Planta 1
28006 Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES
Belgium
EU contribution
€ 0
Address
Rue Du Trone 108/1
1050 Bruxelles
Activity type
Other
MERCK SHARP & DOHME CORP
United States
EU contribution
€ 0
Address
One Merck Drive
08889 Whitehouse Station Nj
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UCB BIOPHARMA
Belgium
EU contribution
€ 0
Address
Allee De La Recherche 60
1070 Bruxelles
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY
United Kingdom
EU contribution
€ 0
Address
105 Victoria Street
SW1E 6QT London
Activity type
Other
AMGEN LIMITED
United Kingdom
EU contribution
€ 0
Address
Cambridge Science Park - Milton Road 240
CB4 0WD Cambridge
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
BAYER AKTIENGESELLSCHAFT
Germany
EU contribution
€ 0
Address
Kaiser-wilhelm-allee 1
51373 Leverkusen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
United Kingdom
EU contribution
€ 0
Address
Great West Road 980
TW89GS Brentford
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
GRUNENTHAL GMBH
Germany
EU contribution
€ 0
Address
Zieglerstrasse 6
52078 Aachen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 0
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ELI LILLY AND COMPANY LTD
United Kingdom
EU contribution
€ 0
Address
Lilly House Basingview
RG21 4FA Basingstoke
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
H. LUNDBECK AS
Denmark
EU contribution
€ 0
Address
Ottiliavej 7-9
2500 Valby
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
Germany
EU contribution
€ 0
Address
Frankfurter Strasse 250
64293 Darmstadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NOVO NORDISK A/S
Denmark
EU contribution
€ 0
Address
Novo Alle 1
2880 Bagsvaerd
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
PFIZER LIMITED
United Kingdom
EU contribution
€ 0
Address
Ramsgate Road
CT13 9NJ Sandwich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
F. HOFFMANN-LA ROCHE AG
Switzerland
EU contribution
€ 0
Address
Grenzacherstrasse 124
4070 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS
France
EU contribution
€ 0
Address
Rue Carnot 50
92284 Courbevoie
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV
Germany
EU contribution
€ 0
Address
Hausvogteiplatz 13
10117 Berlin
Activity type
Other
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
France
EU contribution
€ 0
Address
Pierre Brossolette 1
91380 Chilly Mazarin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NOVARTIS PHARMA AG
Switzerland
EU contribution
€ 0
Address
Lichtstrasse 35
4056 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED
United Kingdom
EU contribution
€ 0
Address
Otley Road
HG3 IPY Harrogate
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ALEXION SERVICES EUROPE SPRL
Belgium
EU contribution
€ 0
Address
Square De Meus 23
1000 Brussels
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
TEAM - IT RESEARCH SL
Spain
EU contribution
€ 73 902,85
Address
Passe De Gracia 58 Planta 4 Puerta 2
08007 Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)